Results 161 to 170 of about 1,483 (209)

Robotic Surgery in Pediatric Urooncology: Radical Cystoprostatectomy

Videourology™
Summary: This video demonstrates port placement, operative positioning, and technical nuances during robot-assisted radical cystoprostatectomy in a pediatric patient with embryonal rhabdomyosarcoma.
B. Onal, E. A. Kırlı, Muhammet Demirbilek, Goktug Kalender, Fatiş Altındaş, Emre Akkuş   +5 more
semanticscholar   +2 more sources

Mental health as part of the integrative palliative care in all levels of care in urooncology

Aging & Mental Health, 2022
H. García-Perdomo, Isabel Carolina Osorio Lasso   +1 more
semanticscholar   +3 more sources

Computer Assisted Robotic Surgery in Urooncology [PDF]

Indian Journal of Surgical Oncology, 2012
Robotic surgery is a significant advance in the realm of urologic surgery esp. for uro genital cancers and reconstructive procedures. Robotic surgery is associated with precision and ease in dissection, incision and suturing with less steep learning curve in comparison to laparoscopy. It provides all benefits of minimally invasive surgery.
Narmada P Gupta
exaly   +3 more sources

MP32-10 THE CANCER OF THE BLADDER RISK ASSESSMENT (COBRA) SCORE AND MORTALITY-SURVIVAL RELATIONSHIP IN PATIENTS WHO HAVE UNDERGONE RADICAL CYSTECTOMY IN THE TURKISH UROONCOLOGY ASSOCIATION DATABASE

Journal of Urology, 2023
muscle ...
H. Tavukcu, I. Tinay, V. Izol, S. Baltacı, K. Teke, E. Süer, U. Yücetaş, S. Yazıcı, S. Akan, B. Şahin, Members Of Urooncology   +10 more
semanticscholar   +1 more source

V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures

European Urology
S. K. Pratihar, A. Singh, A. Khanna, B. Kumar, N. Saurabh, I. Malla, D. Tomar, S. Rawal   +7 more
semanticscholar   +2 more sources

Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey

Urologia internationalis, 2021
Background: Epstein criteria based on sextant biopsy are assumed to be valid for 12-core biopsies. However, very scarce information is present in the current literature to support this view. Objectives: To investigate the validity of Epstein criteria for
S. Çelik, F. Kızılay, Kutsal Yörükoğlu, G. Aslan, H. Ozen, B. Akdogan, S. Sozen, S. Baltacı, T. Muezzinoğlu, V. Izol, Y. Bayazıt, F. Narter, L. Türkeri   +12 more
semanticscholar   +1 more source

Optimizing Unilateral Pelvic Lymph Node Dissection in the PSMA Era: Balancing Oncological Safety, Contralateral Involvement Risk, and Overtreatment in Prostate Cancer: A Multicenter Study of the Turkish Urooncology Association.

Clinical Genitourinary Cancer
OBJECTIVE To evaluate the risk of contralateral lymph node involvement (LNI) and the feasibility of safely performing unilateral pelvic lymph node dissection (PLND) in unfavorable-intermediate and high-risk prostate cancer (PCa) patients with cN0 status ...
Çağrı Akpınar, E. Suer, Nejdet Karşıyakalı, N. Karakoyunlu, S. Çetin, G. Aslan, Deniz Bolat, V. Izol, C. Bilen, S. Sozen, L. Türkeri, Sümer Baltacı   +11 more
semanticscholar   +1 more source

[Update Urooncology: News from major scientific meetings 2018].

Aktuelle Urologie, 2019
We are living in exciting times for urological oncology. The numbers of clinical trials are ever rising, a stream of new substances for tumour therapy is introduced. As it is more challenging than ever to obtain an overview as a clinician, this article aims to summarise the most important news with regard to the 3 most eminent urological tumour ...
H. Heers, M. Boegemann, A. Hegele
semanticscholar   +3 more sources

Positron emission tomography (PET) in the urooncological evaluation of the small pelvis

World Journal of Urology, 2007
Positron emission tomography (PET) with the use of ((18)F)2-fluoro-D: -2-desoxyglucose (FDG) has been investigated to be a highly sensitive and specific imaging modality in the diagnostic of primary and recurrent tumors and in the control of therapies in numerous non-urologic cancers.
S, Machtens, J, Serth, A, Meyer, C, Kleinhorst, K-J, Ommer, U, Herbst, M, Kieruij, A R, Boerner   +7 more
openaire   +2 more sources

Analysis of risk factors for cancer-specific survival in neoadjuvant chemotherapy nonresponsive disease of muscle-invasive bladder cancer: A multicentre study from the Turkish Urooncology Association Bladder Tumor study group.

Urologic oncology
OBJECTIVE To investigate the risk factors affecting cancer-specific survival (CSS) in nonresponsive disease to neoadjuvant chemotherapy (NAC) among patients with muscle-invasive bladder cancer (MIBC) who were treated with NAC and radical cystectomy (RC).
K. Teke, Hasan Yılmaz, Sümer Baltacı, M. Akgül, Bahadır Şahin, L. Türkeri, O. Bozkurt, U. Yücetaş, G. Aslan, Deniz Bolat, V. Izol, T. A. Ozkan, S. Eskiçorapçı   +12 more
semanticscholar   +1 more source